For example, gain-of-function mutations in DYRK1B have been linked to familial forms of obesity and metabolic syndrome, highlighting the importance of DYRK1B in regulating metabolic pathways (Keramati et al., 2014; Abu Jhaisha et al., 2017). Here, DYRK1B is linked to metabolic syndrome.